Literature DB >> 8879125

Host-range restriction of vaccinia virus E3L-specific deletion mutants.

E Beattie1, E B Kauffman, H Martinez, M E Perkus, B L Jacobs, E Paoletti, J Tartaglia.   

Abstract

The vaccinia virus (VV) E3L gene product functions as a dsRNA binding protein that is involved in conferring an interferon-resistant phenotype upon the virus. Studies with a vaccinia virus (VV) E3L- deletion mutant (vP1080) have also demonstrated that the E3L gene product is critical for productive replication on certain cell substrates. While E3L was found to be nonessential for replication in chick embryo fibroblasts (CEFs), virus specifically deleted of E3L was found to be replication deficient in Vero, HeLa, and murine L929 cells. Further, the temporal block in replication appears to differ in these cell systems, as evidenced by the observed timing of protein synthesis inhibition. In Vero cells infected with the VV E3L- mutant, there was no detectable protein synthesis after 2 hr post-infection, whereas in L929 cells normal protein patterns were observed even at late times post-infection. Expression of a heterologous dsRNA binding protein, the reovirus sigma 3 protein, by the E3L- mutant virus restored near wild-type growth characteristics, suggesting the critical nature for regulating dsRNA levels in VV-infected cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8879125     DOI: 10.1007/bf00370005

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  24 in total

1.  Distinct patterns of IFN sensitivity observed in cells infected with vaccinia K3L- and E3L- mutant viruses.

Authors:  E Beattie; E Paoletti; J Tartaglia
Journal:  Virology       Date:  1995-07-10       Impact factor: 3.616

2.  Localization and sequence of a vaccinia virus gene required for multiplication in human cells.

Authors:  S Gillard; D Spehner; R Drillien; A Kirn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase.

Authors:  J C Watson; H W Chang; B L Jacobs
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

4.  Host range restriction of vaccinia virus in Chinese hamster ovary cells: relationship to shutoff of protein synthesis.

Authors:  R Drillien; D Spehner; A Kirn
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

Review 5.  Control of gene expression at the level of translation initiation.

Authors:  R J Kaufman
Journal:  Curr Opin Biotechnol       Date:  1994-10       Impact factor: 9.740

6.  Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene.

Authors:  H Yuwen; J H Cox; J W Yewdell; J R Bennink; B Moss
Journal:  Virology       Date:  1993-08       Impact factor: 3.616

7.  Characterization of a specific kinase inhibitory factor produced by vaccinia virus which inhibits the interferon-induced protein kinase.

Authors:  P Whitaker-Dowling; J S Youngner
Journal:  Virology       Date:  1984-08       Impact factor: 3.616

8.  Temperature-sensitive mutants in the vaccinia virus A18R gene increase double-stranded RNA synthesis as a result of aberrant viral transcription.

Authors:  C D Bayliss; R C Condit
Journal:  Virology       Date:  1993-05       Impact factor: 3.616

9.  The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms.

Authors:  M V Davies; H W Chang; B L Jacobs; R J Kaufman
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR.

Authors:  H Park; M V Davies; J O Langland; H W Chang; Y S Nam; J Tartaglia; E Paoletti; B L Jacobs; R J Kaufman; S Venkatesan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

View more
  54 in total

1.  Regulation of vaccinia virus E3 protein by small ubiquitin-like modifier proteins.

Authors:  José González-Santamaría; Michela Campagna; María Angel García; Laura Marcos-Villar; Dolores González; Pedro Gallego; Fernando Lopitz-Otsoa; Susana Guerra; Manuel S Rodríguez; Mariano Esteban; Carmen Rivas
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Suppression of proinflammatory signal transduction and gene expression by the dual nucleic acid binding domains of the vaccinia virus E3L proteins.

Authors:  Jeffrey O Langland; John C Kash; Victoria Carter; Matthew J Thomas; Michael G Katze; Bertram L Jacobs
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  ISG15 is counteracted by vaccinia virus E3 protein and controls the proinflammatory response against viral infection.

Authors:  Benedito Eduardo-Correia; Carles Martínez-Romero; Adolfo García-Sastre; Susana Guerra
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

4.  Identification of 10 cowpox virus proteins that are necessary for induction of hemorrhagic lesions (red pocks) on chorioallantoic membranes.

Authors:  Zhiyong Xu; Dimitrios Zikos; Aistė Tamošiūnaitė; Robert Klopfleisch; Nikolaus Osterrieder; B Karsten Tischer
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

Review 5.  Silencing suppressors: viral weapons for countering host cell defenses.

Authors:  Liping Song; Shijuan Gao; Wei Jiang; Shuai Chen; Yanjun Liu; Ling Zhou; Wenlin Huang
Journal:  Protein Cell       Date:  2011-04-27       Impact factor: 14.870

6.  Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells.

Authors:  K V Kibler; T Shors; K B Perkins; C C Zeman; M P Banaszak; J Biesterfeldt; J O Langland; B L Jacobs
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122.

Authors:  Liang-Tzung Lin; Ryan S Noyce; Tram N Q Pham; Joyce A Wilson; Gary R Sisson; Thomas I Michalak; Karen L Mossman; Christopher D Richardson
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

8.  Poxvirus decapping enzymes enhance virulence by preventing the accumulation of dsRNA and the induction of innate antiviral responses.

Authors:  Shin-Wu Liu; George C Katsafanas; Ruikang Liu; Linda S Wyatt; Bernard Moss
Journal:  Cell Host Microbe       Date:  2015-03-11       Impact factor: 21.023

9.  Expression of the E3L gene of vaccinia virus in transgenic mice decreases host resistance to vaccinia virus and Leishmania major infections.

Authors:  Elena Domingo-Gil; Eva Pérez-Jiménez; Iván Ventoso; José L Nájera; Mariano Esteban
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

10.  Response of Three Different Viruses to Interferon Priming and Dithiothreitol Treatment of Avian Cells.

Authors:  Irene Lostalé-Seijo; José Martínez-Costas; Javier Benavente
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.